Hikma Pharmaceuticals falls Friday, underperforms market
Hikma Pharmaceuticals PLC HIK shares shed 1.04% to £19.93 Friday, on what proved to be an all-around grim trading session for ...
Hikma Pharmaceuticals rises Thursday, still underperforms market
Shares of Hikma Pharmaceuticals PLC HIK rallied 1.05% to £20.14 Thursday, on what proved to be an all-around favorable ...
Hikma Pharmaceuticals (OTCMKTS:HKMPF) Shares Up 3.7% – Here’s What Happened
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF – Get Free Report)’s stock price rose 3.7% on Friday . The company traded as high as $25.02 and last traded at $25.02. Approximately 3,835 shares were traded ...
Insider Monkey on MSN7d
Is Hikma Pharmaceuticals PLC (HIK.L) Among the U.K. Dividend Aristocrats for 2024?
In this article, we are going to take a look at where Hikma Pharmaceuticals PLC (LON:HIK.L) stands against the other U.K.
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug ...
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
The Healthy on MSN3d
FDA Announcement: The First Generic GLP-1 Shot Has Just Been Approved
This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
Hikma Pharmaceuticals (LON:HIK) Stock Price Crosses Above 200 Day Moving Average – Time to Sell?
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,922.34 ($24.05) ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
The Jordan Times1d
'Kingdom's pharmaceutical industry grows by 19% in 2024, national products reach 80 markets worldwide'
The Kingdom's pharmaceutical industry has seen "remarkable" improvement during the past few years, thanks to His Majesty King Abdullah's support, an official from the Jordan Chamber of Industry (JCI) ...
McKnight's Long-Term Care News5d
FDA approves first generic liraglutide once-daily injection
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...
New York Post13d
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...